418 related articles for article (PubMed ID: 32719099)
1. Biallelic variants in
Maroofian R; Sedmík J; Mazaheri N; Scala M; Zaki MS; Keegan LP; Azizimalamiri R; Issa M; Shariati G; Sedaghat A; Beetz C; Bauer P; Galehdari H; O'Connell MA; Houlden H
J Med Genet; 2021 Jul; 58(7):495-504. PubMed ID: 32719099
[TBL] [Abstract][Full Text] [Related]
2. Bi-allelic ADARB1 Variants Associated with Microcephaly, Intellectual Disability, and Seizures.
Tan TY; Sedmík J; Fitzgerald MP; Halevy RS; Keegan LP; Helbig I; Basel-Salmon L; Cohen L; Straussberg R; Chung WK; Helal M; Maroofian R; Houlden H; Juusola J; Sadedin S; Pais L; Howell KB; White SM; Christodoulou J; O'Connell MA
Am J Hum Genet; 2020 Apr; 106(4):467-483. PubMed ID: 32220291
[TBL] [Abstract][Full Text] [Related]
3. ADAR RNA editing in human disease; more to it than meets the I.
Gallo A; Vukic D; Michalík D; O'Connell MA; Keegan LP
Hum Genet; 2017 Sep; 136(9):1265-1278. PubMed ID: 28913566
[TBL] [Abstract][Full Text] [Related]
4. Comparative Activity of Adenosine Deaminase Acting on RNA (ADARs) Isoforms for Correction of Genetic Code in Gene Therapy.
Azad MTA; Qulsum U; Tsukahara T
Curr Gene Ther; 2019; 19(1):31-39. PubMed ID: 30426900
[TBL] [Abstract][Full Text] [Related]
5. Biallelic GRM7 variants cause epilepsy, microcephaly, and cerebral atrophy.
Marafi D; Mitani T; Isikay S; Hertecant J; Almannai M; Manickam K; Abou Jamra R; El-Hattab AW; Rajah J; Fatih JM; Du H; Karaca E; Bayram Y; Punetha J; Rosenfeld JA; Jhangiani SN; Boerwinkle E; Akdemir ZC; Erdin S; Hunter JV; Gibbs RA; Pehlivan D; Posey JE; Lupski JR
Ann Clin Transl Neurol; 2020 May; 7(5):610-627. PubMed ID: 32286009
[TBL] [Abstract][Full Text] [Related]
6. The RNA editing enzyme ADAR2 restricts L1 mobility.
Frassinelli L; Orecchini E; Al-Wardat S; Tripodi M; Mancone C; Doria M; Galardi S; Ciafrè SA; Michienzi A
RNA Biol; 2021 Oct; 18(sup1):75-87. PubMed ID: 34224323
[TBL] [Abstract][Full Text] [Related]
7. Asymmetric dimerization of adenosine deaminase acting on RNA facilitates substrate recognition.
Thuy-Boun AS; Thomas JM; Grajo HL; Palumbo CM; Park S; Nguyen LT; Fisher AJ; Beal PA
Nucleic Acids Res; 2020 Aug; 48(14):7958-7972. PubMed ID: 32597966
[TBL] [Abstract][Full Text] [Related]
8. An RNA editing/dsRNA binding-independent gene regulatory mechanism of ADARs and its clinical implication in cancer.
Qi L; Song Y; Chan THM; Yang H; Lin CH; Tay DJT; Hong H; Tang SJ; Tan KT; Huang XX; Lin JS; Ng VHE; Maury JJP; Tenen DG; Chen L
Nucleic Acids Res; 2017 Oct; 45(18):10436-10451. PubMed ID: 28985428
[TBL] [Abstract][Full Text] [Related]
9. Adenosine Deaminases Acting on RNA (ADARs) and Viral Infections.
Pfaller CK; George CX; Samuel CE
Annu Rev Virol; 2021 Sep; 8(1):239-264. PubMed ID: 33882257
[TBL] [Abstract][Full Text] [Related]
10. A comparative analysis of ADAR mutant mice reveals site-specific regulation of RNA editing.
Costa Cruz PH; Kato Y; Nakahama T; Shibuya T; Kawahara Y
RNA; 2020 Apr; 26(4):454-469. PubMed ID: 31941663
[TBL] [Abstract][Full Text] [Related]
11. Adenosine deaminases acting on RNA, RNA editing, and interferon action.
George CX; Gan Z; Liu Y; Samuel CE
J Interferon Cytokine Res; 2011 Jan; 31(1):99-117. PubMed ID: 21182352
[TBL] [Abstract][Full Text] [Related]
12. Serotonin-2C receptor pre-mRNA editing in rat brain and in vitro by splice site variants of the interferon-inducible double-stranded RNA-specific adenosine deaminase ADAR1.
Liu Y; Emeson RB; Samuel CE
J Biol Chem; 1999 Jun; 274(26):18351-8. PubMed ID: 10373439
[TBL] [Abstract][Full Text] [Related]
13. A disrupted RNA editing balance mediated by ADARs (Adenosine DeAminases that act on RNA) in human hepatocellular carcinoma.
Chan TH; Lin CH; Qi L; Fei J; Li Y; Yong KJ; Liu M; Song Y; Chow RK; Ng VH; Yuan YF; Tenen DG; Guan XY; Chen L
Gut; 2014 May; 63(5):832-43. PubMed ID: 23766440
[TBL] [Abstract][Full Text] [Related]
14. Aberrant alternative splicing pattern of ADAR2 downregulates adenosine-to-inosine editing in glioma.
Li Z; Tian Y; Tian N; Zhao X; Du C; Han L; Zhang H
Oncol Rep; 2015 Jun; 33(6):2845-52. PubMed ID: 25873329
[TBL] [Abstract][Full Text] [Related]
15. The properties of a tRNA-specific adenosine deaminase from Drosophila melanogaster support an evolutionary link between pre-mRNA editing and tRNA modification.
Keegan LP; Gerber AP; Brindle J; Leemans R; Gallo A; Keller W; O'Connell MA
Mol Cell Biol; 2000 Feb; 20(3):825-33. PubMed ID: 10629039
[TBL] [Abstract][Full Text] [Related]
16. Adenosine Deaminase Acting on RNA (ADAR) Enzymes: A Journey from Weird to Wondrous.
Keegan LP; Hajji K; O'Connell MA
Acc Chem Res; 2023 Nov; 56(22):3165-3174. PubMed ID: 37906879
[TBL] [Abstract][Full Text] [Related]
17. ADAR2 Is Involved in Self and Nonself Recognition of Borna Disease Virus Genomic RNA in the Nucleus.
Yanai M; Kojima S; Sakai M; Komorizono R; Tomonaga K; Makino A
J Virol; 2020 Feb; 94(6):. PubMed ID: 31852792
[TBL] [Abstract][Full Text] [Related]
18. The majority of A-to-I RNA editing is not required for mammalian homeostasis.
Chalk AM; Taylor S; Heraud-Farlow JE; Walkley CR
Genome Biol; 2019 Dec; 20(1):268. PubMed ID: 31815657
[TBL] [Abstract][Full Text] [Related]
19. ADAR2 enzymes: efficient site-specific RNA editors with gene therapy aspirations.
Hajji K; Sedmík J; Cherian A; Amoruso D; Keegan LP; O'Connell MA
RNA; 2022 Oct; 28(10):1281-1297. PubMed ID: 35863867
[TBL] [Abstract][Full Text] [Related]
20. Double-stranded RNA adenosine deaminases ADAR1 and ADAR2 have overlapping specificities.
Lehmann KA; Bass BL
Biochemistry; 2000 Oct; 39(42):12875-84. PubMed ID: 11041852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
